Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 3/2019

Ausgabe 3/2019

Inhaltsverzeichnis ( 21 Artikel )

11.05.2019 | Review Article | Ausgabe 3/2019

The role of thioredoxin system in cancer: strategy for cancer therapy

Jin-Jing Jia, Wen-Shuo Geng, Zhan-Qi Wang, Lei Chen, Xian-Si Zeng

18.06.2019 | Review Article | Ausgabe 3/2019 Open Access

Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review

Marie Lindhard Madsen, Hanne Due, Niels Ejskjær, Paw Jensen, Jakob Madsen, Karen Dybkær

15.07.2019 | Review Article | Ausgabe 3/2019 Open Access

Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes

Maarten van Eijk, René J. Boosman, Alfred H. Schinkel, Alwin D. R. Huitema, Jos H. Beijnen

24.04.2019 | Original Article | Ausgabe 3/2019

Application of time-dependent modeling for the exposure–efficacy analysis of ceritinib in untreated ALK-rearranged advanced NSCLC patients

Yvonne Y. Lau, Wen Gu, Yu-Yun Ho, Ying Hong, Xinrui Zhang, Patrick Urban

17.04.2019 | Original Article | Ausgabe 3/2019

Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatment

Oznur Yigit, Mavis Emel Kulak Kayikci, Cagri Mesut Temucin, Sarp Sarac, Mustafa Erman, Erol Belgin

17.04.2019 | Original Article | Ausgabe 3/2019

BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alpha

Faruk Tas, Kayhan Erturk

27.04.2019 | Original Article | Ausgabe 3/2019

In vitro evaluation of FL118 and 9-Q20 cytotoxicity and cellular uptake in 2D and 3D different cell models

Qi Weng, Leilei Zhou, Lihua Xia, Yixin Zheng, Xiangli Zhang, Fengzhi Li, Qingyong Li

10.06.2019 | Original Article | Ausgabe 3/2019 Open Access

Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer

Whitney P. Kirschbrown, Bei Wang, Ihsan Nijem, Atsushi Ohtsu, Paulo M. Hoff, Manish A. Shah, Lin Shen, Yoon-Koo Kang, Maria Alsina, Sandhya Girish, Amit Garg

25.05.2019 | Original Article | Ausgabe 3/2019

Identification of dinactin, a macrolide antibiotic, as a natural product-based small molecule targeting Wnt/β-catenin signaling pathway in cancer cells

Aehtesham Hussain, Mohd Saleem Dar, Nasima Bano, Md Mehedi Hossain, Rafia Basit, Aadil Qadir Bhat, Mushtaq A. Aga, Sabeena Ali, Qazi Parvaiz Hassan, Mohd Jamal Dar

21.05.2019 | Original Article | Ausgabe 3/2019

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study

Masaki Shiota, Motonobu Nakamura, Akira Yokomizo, Toshihisa Tomoda, Naotaka Sakamoto, Narihito Seki, Shuji Hasegawa, Takakazu Yunoki, Masahiko Harano, Kentaro Kuroiwa, Masatoshi Eto

12.06.2019 | Original Article | Ausgabe 3/2019

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

Sanjay Goel, Umang Swami, Kirushna Kumar, Christian Dittrich, Larisa Reyderman, Minish Jain, Joseph Aisner, James Song, Daniel P. Petrylak

13.07.2019 | Original Article | Ausgabe 3/2019

Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitors

Rex M. Philpot, M. Ficken, B. E. Johns, M. E. Engberg, L. Wecker

15.06.2019 | Original Article | Ausgabe 3/2019

Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study

Sofya Pintova, Sirish Dharmupari, Erin Moshier, Nicole Zubizarreta, Celina Ang, Randall F. Holcombe

15.06.2019 | Original Article | Ausgabe 3/2019

Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients

Xuan Jin, Yu Bai, Lan Gao, Shikai Wu

11.07.2019 | Original Article | Ausgabe 3/2019

A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer

Lu Cao, Guomin Xiang, Fang Liu, Cong Xu, Jing Liu, Qingxiang Meng, Shuhua Lyu, Shuling Wang, Yun Niu

06.07.2019 | Original Article | Ausgabe 3/2019

Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure–QTc in patients with advanced or refractory solid tumors

Elodie Valade, Anne-Gaëlle Dosne, Hong Xie, Robert Kleiman, Lilian Y. Li, Juan José Perez-Ruixo, Daniele Ouellet

22.06.2019 | Original Article | Ausgabe 3/2019

Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response

Xing Xu, Guoliang Zheng, Tao Zhang, Yan Zhao, Zhichao Zheng

22.06.2019 | Original Article | Ausgabe 3/2019

The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients

Utako Ishimoto, Akiyoshi Kinoshita, Yuki Hirose, Keiko Shibata, Ayako Ishii, Ryo Shoji, Takeharu Yokota, Akira Iwaku, Yusuke Mizuno, Kazuhiko Koike, Masayuki Saruta

27.06.2019 | Original Article | Ausgabe 3/2019 Open Access

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study

Mie Kotake, Hisao Imai, Kyoichi Kaira, Tomomi Fujisawa, Yasuhiro Yanagita, Koichi Minato

21.03.2019 | Short Communication | Ausgabe 3/2019

Rituximab dosing in hematological malignancies: an old question, revisited

Peter N. Morcos, Axel Boehnke, Nancy Valente, Donald E. Mager

10.07.2019 | Correction | Ausgabe 3/2019 Open Access

Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin®) in patients with HER2‑positive metastatic breast cancer

Xiaoying Chen, Cheryl Li, Reginald Ewesuedo, Donghua Yin

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise